Navigation Links
Kinex Pharmaceuticals Appoints Mr. Patrick Gallagher Vice President of Business Development and Investor Relations

BUFFALO, N.Y., Sept. 10, 2012 /PRNewswire/ -- Kinex Pharmaceuticals, LLC announced the appointment of Mr. Patrick (Pat) Gallagher to the position of Vice President, Business Development and Investor Relations.  Mr. Gallagher will report to Johnson Lau, MBBS, MD, FRCP, Kinex's Chief Executive Officer.

"Pat joins Kinex's management team at a time when his experience will be invaluable to the strategic growth of Kinex," said Dr. Johnson Lau. "Having known Pat for 12 years, I am delighted to welcome his deep insight and expertise in the biotechnology space, which will be instrumental in helping us to plan for our next phase of company growth. He was an early investor in Kinex and we have enjoyed his many years of invaluable advice to the company."

"Pat's vast network in both the biotechnology space and Wall Street will be extremely useful in assisting us to navigate through the next stage of company development," stated Mr. Chuck Lannon, Vice President of the Board and Chair of the Nomination and Corporate Governance Committee. 

"This strong vote of confidence in Kinex and our pipeline from a Wall Street veteran such as Pat sends a powerful message about the strength of our team and the value of our products," said Dr. Jean-Pierre Sommadossi, Board member and Founder and former Chairman and CEO, Idenix.

Mr. Gallagher, CFA is an accomplished Capital Markets Executive, Advisor, and Investor with a distinguished record of success in both the public and private markets. He has nearly 20 years of experience on Wall Street and extensive expertise in alternative investments, capital markets, and marketing.  He is a founding partner and was CEO of BDR Research Group, LLC; a healthcare focused institutional research boutique specialized in providing services for clients in the healthcare investing, financing, and operations areas.  Mr. Gallagher is also a Managing Director of Potomac Management Group, a strategic consulting group. Prior, Mr. Gallagher worked for investment and research firms Kidder Peabody, PaineWebber and New Vernon Associates. 

About Kinex Pharmaceuticals, LLC

Kinex Pharmaceuticals, headquartered in Buffalo, New York, USA, is using its proprietary technologies Mimetica™ and Opal™ to discover and develop novel drugs for oncology and immune-modulatory diseases. More information of Kinex Pharmaceuticals can be found at  

Kinex Pharmaceuticals, LLC Caution Regarding Forward-looking Information

Under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, Kinex Pharmaceuticals cautions investors that any forward-looking statements or projections made by Kinex Pharmaceuticals, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected.


Kinex Pharmaceuticals

Investors: Mr. Patrick Gallagher



SOURCE Kinex Pharmaceuticals, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Kinex Pharmaceuticals Receives Substantial Strategic Investment
2. Xiangxue Pharmaceuticals to Acquire Rights for a Promising Drug Candidate from Kinex Pharmaceuticals for the Greater China Territory
3. Robert G. Savage, Former Worldwide Chairman, Johnson & Johnsons Pharmaceuticals Group, Joins Board of Nuovo Biologics, LLC
4. AcelRx Pharmaceuticals to Present at the UBS Global Life Sciences Conference
5. The SFJ Pharmaceuticals Group Announces Agreement With Pfizer to Co-develop Dacomitinib as First-Line Treatment for Patients With Advanced Non-small Cell Lung Cancer
6. Actinium Pharmaceuticals Commences Screening for the Second Cohort of Patients in the Companys Ongoing Phase I/II Trial in Acute Myeloid Leukemia
7. Jazz Pharmaceuticals Announces Participation At The 2012 Morgan Stanley Global Healthcare Conference In New York On September 11
8. Cumberland Pharmaceuticals to Present at the UBS Global Life Sciences Conference in New York
9. Actinium Pharmaceuticals Stockholders Vote to Approve Fundraising and Public Listing
10. Global Markets for Membrane Technology for Pharmaceuticals
11. Inovio Pharmaceuticals Takes Major Stride Toward Universal Influenza Vaccine
Post Your Comments:
(Date:11/26/2015)... , 26 november 2015 AAIPharma ... de geplande investering aan van ten minste ... laboratoria en het mondiale hoofdkantoor in ... zal resulteren in extra kantoorruimte en extra ... de groeiende behoeften van de farmaceutische en ...
(Date:11/26/2015)... FRANCISCO , November 26, 2015 ... billion by 2022, according to a new report by Grand ... Chronic Kidney Disease (CKD) which demands kidney transplantation is expected ... and cost effective substitute for organ transplantation. --> ... billion by 2022, according to a new report by Grand ...
(Date:11/26/2015)... 26, 2015 ... ser potential att använda SyMRI för att ... för patienter med multipel skleros (MS) eller ... SyntheticMR AB för att kunna använda SyMRI ... Med SyMRI kan man generera flera konstrastbilder ...
Breaking Medicine Technology:
(Date:11/28/2015)... ... 2015 , ... Pixel Film Studios is back again with ProPanel: Pulse ... are endless. Users have full control over angle of view, speed method, start point, ... sure to get heads to turn. , ProPanel: Pulse offers fully customizable pulsating shape ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... way that they are handling security in light of the recent terrorist attacks in ... an attempt to stop an attack from reaching U.S. soil. Especially around special events ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... were," said an inventor from Hillside, N.J. "Many people catch diseases simply from ... that individuals will always be protected from germs." , He developed the patent-pending ...
(Date:11/27/2015)... ... ... Herpes-only dating community in the world, revealed that over 50% of its members are under ... under the age of 50 – or 67% of the population - are infected with ... infection . , "The data shocks us highly!" said Michelle Li, Co-Founder of the ...
(Date:11/27/2015)... MINNEAPOLIS, Minn. (PRWEB) , ... November 27, 2015 ... ... you start failing. Secura Consultants has prided itself for not only fulfilling the ... best income protection solutions at an affordable price and providing top-tier customer service. ...
Breaking Medicine News(10 mins):